Implantation Technique, Continuous Implant Geometry, and Longitudinal Low‐Voltage Impedance After Subcutaneous Implantable Cardioverter‐Defibrillator Implantation
Year: 2026
Type: article
Study design: Observational Study
Abstract: BACKGROUND: Defibrillation efficacy of the subcutaneous implantable cardioverter-defibrillator (S-ICD) depends on shock vector geometry and tissue impedances influenced by implantation technique. Whether longitudinal low-voltage impedance (LVI) measurements differ across contemporary implantation strategies, and whether these differences are explained by quantitative radiographic geometry, remains incompletely characterized. OBJECTIVE: To determine whether S-ICD implantation technique is associated with longitudinal LVI trajectories and whether continuous radiographic implant geometry provides information beyond categorical PRAETORIAN risk classification. METHODS: We performed a single-center retrospective cohort study of 136 adults receiving an S-ICD between 2014 and 2024, classified by operative documentation as subcutaneous (SC; n = 27), fluoroscopy-marked intermuscular (FIM; n = 73), or fluoroscopy-marked ultrasound-guided intermuscular (FUSIM; n = 36) techniques. Per-device LVI was summarized overall and across prespecified windows (0-30 days, 6 months-1 year, 2-5 years). Technique differences were analyzed. We fit a prespecified mixed-effects interaction model that included coil-sternum distance, scaled in 5 mm increments, and assessed correlations between LVI and radiographic measures. RESULTS: In paired analyses, LVI increased by a mean of 13.3 Ω between the 0-30-day and 2-5-year windows. Overall LVI differed by implantation technique (Kruskal-Wallis p = 0.019), driven by higher values in SC versus FIM (Holm-adjusted p = 0.041) and FUSIM (p = 0.022). Additional impedance differences across techniques were absent in the 0-30-day window but emerged during follow-up. In the prespecified interaction mixed-effects model, SC exhibited a significant additional rise relative to FUSIM during the 2-5-year window (interaction β = 7.82 Ω, 95% CI 0.98-14.67; p = 0.025). Greater coil-sternum distance was independently associated with higher LVI (13.6 Ω per cm, 95% CI 4.2-23.0; p = 0.005) and correlated with chronic LVI (n = 76; r = 0.441; Benjamini-Hochberg q < 0.001). The PRAETORIAN score was computable in 76 devices and classified 84% as low risk; within that low-risk stratum, coil-sternum distance remained associated with chronic LVI (ρ = 0.320, p = 0.010) whereas the score did not (ρ = 0.136, p = 0.282), and each 5 mm of coil-sternum distance corresponded to 10.7 Ω higher LVI after adjustment for BMI (95% CI 2.68-18.73, p = 0.010). High-voltage shock impedance at implant correlated strongly with chronic LVI (n = 99; r = 0.71, p < 0.001), and the association persisted over 2-5 years (n = 69; r = 0.61, p < 0.001). CONCLUSION: Longitudinal LVI varies with S-ICD implantation strategy, with time-dependent divergence between SC and intermuscular implants. Within the low-risk PRAETORIAN category, where the categorical score has no dynamic range, continuously measured coil-sternum distance remains associated with chronic impedance. Continuous implant geometry and longitudinal impedance complement, rather than replace, radiographic scoring of implant position.
DOI: 10.1111/jce.70568
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W7235177003
